Description: Learn about OCREVUS ZUNOVO® (ocrelizumab & hyaluronidase-ocsq) subcutaneous injections and OCREVUS® (ocrelizumab) infusions. These prescription medicines are used for multiple sclerosis (MS) treatment in adults with relapsing or primary progressive multiple sclerosis. See full safety for more information.
† This is only administration time and does not account for all aspects of treatment. Actual clinic time may vary. The duration of an infusion or injection could be longer should a reaction occur. ‡ For eligible patients who have not previously experienced any serious infusion reactions with OCREVUS
That’s one reason people choose OCREVUS ® * and OCREVUS ZUNOVO™. Discover more and get a side-by-side look at how these two options for treating MS are administered.
*For OCREVUS, your first dose will be split into 2, for a total of 3 treatments your first year.